Licensing deal positions KemPharm's Apadaz for launch
Coralville-based KemPharm this week announced it has entered into a license agreement with KVK Tech Inc. for U.S. commercial rights to its FDA-approved prodrug, Apadaz.
IDx, Topcon sign exclusive AI platform agreement
IDx, the Coralville company behind the first and only FDA-cleared autonomous AI diagnostic system, has announced a new agreement with Topcon, a leading ophthalmic device manufacturer, to scale delivery of AI diagnostic solutions in the U.S. market.
Foundations in Learning Launches iASK, an Online Screener and Diagnostic Tool for Struggling Readers
Developed specifically for the middle school market, iASK is a validated and reliable online assessment that represents the culmination of four years of research and development
Santos Warfighter Program Welcomes SPAWAR Atlantic
Iowa Company helps the US DoD decrease cost of optimizing Warfighter-operated equipment
Innovas Technologies renews contract with University of Virginia
Coralville-based Innovas Technologies has renewed its sole source supplier agreement with the University of Virginia (UVA), the company announced this week.
UI spinout aims to make products a bit more human
Steve Beck, president and CEO of SantosHuman Inc., located in the University of Iowa’s BioVentures Center, says the company’s human-centric approach to product design can save manufacturers millions in lost time and costly redesign.
University of Iowa Health Care first to adopt IDx-DR in a diabetes care setting
IDx-DR, the first autonomous AI diagnostic system cleared by the FDA, is now being used in patient care at University of Iowa Health Care.
No fooling new DNA test on smoking, alcohol
CORALVILLE — When it comes to admitting how much they smoke or drink, people aren’t always the most truthful.
FDA permits marketing of IDx-DR for automated detection of diabetic retinopathy in primary care
IDx, a privately-held AI diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company’s De Novo request to market IDx-DR, an AI-based diagnostic system for the autonomous detection of diabetic retinopathy, a leading cause of blindness. IDx-DR is the first autonomous, AI-based diagnostic system authorized for commercialization by the FDA.
FDA approves first product for Coralville-based IDx
IDx, a University of Iowa spinout company based in Coralville, has received FDA approval to market IDX-DR, the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.
Pages
